Insider Buying: Crescita Therapeutics Inc. (TSE:CTX) Director Buys 86,000 Shares of Stock December 29, 2024 by InsiderTrades.com Share Crescita Therapeutics Inc. (TSE:CTX - Get Free Report) Director Jose Darocha purchased 86,000 shares of the business's stock in a transaction on Friday, December 27th. The shares were acquired at an average cost of C$0.60 per share, for a total transaction of C$51,436.60. Crescita Therapeutics Price PerformanceTSE:CTX opened at C$0.60 on Friday. The stock's 50-day simple moving average is C$0.58 and its 200 day simple moving average is C$0.58. Crescita Therapeutics Inc. has a 52-week low of C$0.36 and a 52-week high of C$0.69. The company has a debt-to-equity ratio of 6.02, a quick ratio of 2.29 and a current ratio of 3.37. The company has a market cap of C$11.63 million, a P/E ratio of -4.00 and a beta of 1.69. Crescita Therapeutics Company Profile (Get Free Report)Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.Further ReadingFive stocks we like better than Crescita TherapeuticsWhat Are Some of the Best Large-Cap Stocks to Buy?Buffett Takes the Bait; Berkshire Buys More Oxy in DecemberTSX Venture Exchange (Formerly Canadian Venture Exchange)Top 3 ETFs to Hedge Against Inflation in 2025Stock Market Holidays 2022-2025 - Here’s When the NYSE and NASDAQ Will be ClosedThese 3 Chip Stock Kings Are Still Buys for 2025This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected]. Insider Buying or Selling at Crescita Therapeutics? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Crescita Therapeutics and related companies. More From MarketBeatliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored7 Stocks with Recent Downgrades Worth a Second LookAnalyst ratings can be a key piece of information that investors look for in stock evaluation. Typically, anal...MarketBeatThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored7 ETFs to Invest in Now for Maximum ReturnsIn the last 12 months, many investors have heard that this is a “stock picker's market." This means that...MarketBeatTarget More Reliable Returns in 2025[LIVE] How the Pros are Trading Options in 2025 Charles Payne reveals beginner-friendly options strategies ...Unstoppable Prosperity | Sponsored10 Best Penny Stocks to Buy NowLet's talk penny stocks. We've all played with them at one time or another, buying shares of a company trading...MarketBeat Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored10 Cheap Dividend Stocks to Buy TodayThe stock market has always been unpredictable, but unprecedented world events have made the market even more ...MarketBeat Free Insider Buying and Selling Newsletter Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report. From Our Partnersliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTarget More Reliable Returns in 2025[LIVE] How the Pros are Trading Options in 2025 Charles Payne reveals beginner-friendly options strategies ...Unstoppable Prosperity | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Most Read This MonthAre 2024’s Top Insider Buys a Good Bet for 2025? AppLovin Insiders Sell Shares: Stock Price Indicated Higher Buffett Takes the Bait; Berkshire Buys More Oxy in DecemberJoby Aviation, Inc. (NYSE:JOBY) Insider Didier Papadopoulos Sells 6,005 SharesInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidInsider Selling: SoFi Technologies, Inc. (NASDAQ:SOFI) Director Sells 52,000 Shares of StockSoundHound AI, Inc. (NASDAQ:SOUN) Insider James Ming Hom Sells 58,382 Shares of StockRigetti Computing, Inc. (NASDAQ:RGTI) Director Michael S. Clifton Sells 125,000 SharesRecent ArticlesJohn Alexander Kelly Acquires 2,113 Shares of Precision BioSciences, Inc. (NASDAQ:DTIL) StockCanuc Resources Co. (CVE:CDA) Director Acquires C$10,132.00 in StockInsider Buying: General American Investors Company, Inc. (NYSE:GAM) Insider Buys 427 Shares of StockEyal C. Attar Sells 10,334 Shares of Vor Biopharma Inc. (NYSE:VOR) StockInsider Buying: American Hotel Income Properties REIT LP (TSE:HOT.UN) Director Acquires 26,500 Shares of StockInsider Buying: Vermilion Energy Inc. (TSE:VET) Senior Officer Buys 1,500 Shares of StockTenth Avenue Petroleum Corp. (CVE:TPC) Insider Fern Macdonald Acquires 403,000 SharesInsider Selling: Enliven Therapeutics, Inc. (NASDAQ:ELVN) CFO Sells 900 Shares of Stock
